The short version
Orderly Meds is a flat-rate telehealth provider. As of the August 25, 2026 build, for tirzepatide its lowest 12-month all-in total is $3,288 (month-to-month plan, verified), which places it 19 of 30 ranked telehealth providers; for semaglutide its lowest 12-month all-in total is $1,788 (month-to-month plan, verified), which places it 5 of 13 ranked telehealth providers. Verification status: verified.
The numbers, plan by plan
- Semaglutide (standard, injection, month-to-month plan): $149 per month. Status: verified, checked August 25, 2026. Compounded semaglutide $149 per month.
- Tirzepatide (standard, injection, month-to-month plan): $299 per month after an introductory $149 per month for the first 2 months. Status: verified, checked August 25, 2026. Compounded tirzepatide $299 per month; a starter promotion can make the first two months appear as $149 per month, which is not the recurring price.
Fees and what the price includes
The published price includes the medication and clinical care and shipping, with no separate membership fee. Shipping is included. The clinician consultation is included. The price does not change with dose.
How this pricing structure plays out over a year
The first 2 months cost $149 all-in; from month 3 the recurring cost is $299 a month, so the advertised $149 covers 9% of the first year's spend and the recurring price covers the rest. The price does not move with dose, which removes the largest hidden cost in this market; a patient at 15 mg pays what a patient at 2.5 mg pays.
Compared with the field
On tirzepatide, Orderly Meds's lowest twelve-month total of $3,288 is $1,788 above the lowest (Trimi, $1,500) and above the median of $3,090 across 30 ranked providers, placing it 19 of 30. On the value score it scores 72 against 92 for NexLife, the best-scoring provider; the gap comes from cost, transparency, care. On semaglutide, Orderly Meds's lowest twelve-month total of $1,788 is $732 above the lowest (Sunlight, $1,056) and below the median of $2,100 across 13 ranked providers, placing it 5 of 13. On the value score it scores 72 against 92 for NexLife, the best-scoring provider; the gap comes from cost, transparency, care.
Pharmacy, coverage and cancellation
The provider reports serving all fifty states. Dispensing: 503A (provider-stated for all named pharmacies; a separate page refers to 503A or 503B). Named pharmacies: PerfectRx / PerfectionRx, ProRx, Casa, Pharmacy Hub, SmartPharmaRx. Commitment: month-to-month; prepay discounts offered. Cancellation: Cancel anytime.
Questions to ask Orderly Meds before paying
Ask, in writing: What is the price from month two, and does it change at renewal? Will my dosing instructions state the concentration of the vial you actually ship, and will you reissue them if it changes? A provider that answers all of these promptly is operating in the open; one that will not name its pharmacy has answered the most important question.
What works
Offers both compounded semaglutide and tirzepatide, including oral forms. All-in pricing without a separate membership. Prepay discounts available.
What to weigh against it
Pricing pending verification and has changed since the shortages ended. Pharmacy partners and state coverage not yet verified.
Who should choose Orderly Meds
Patients comparing all-in compounded plans who want oral and injectable options from one provider. A patient with insurance coverage for Zepbound or Wegovy should compare the copay route first; a patient who wants a verified flat all-in price with month-to-month flexibility should compare the best overall provider on our value score; and any patient should ask which pharmacy fills the prescription before paying.
How we verified this
Orderly's pricing page publishes compounded semaglutide at $149 and tirzepatide at $299 per month, with a two-month tirzepatide starter promotion at $149. Its treatment page states that providers prescribe in all 50 states, and its FAQ names PerfectRx/PerfectionRx, ProRx, Casa, Pharmacy Hub and SmartPharmaRx as 503A pharmacies (a separate page refers generically to 503A or 503B). Verified against the provider's own pages on 2026-08-25 (first-party verification pass).